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We report a case involving a young adult who had life-threatening bilateral pneumonitis in the
course of an acute Epstein-Barr virus (EBV) infection. Because of severe hypoxemia, the patient
required mechanical ventilation and additional oxygenation by an intravascular oxygenator. The
patient was treated with corticosteroids and survived without sequelae. Severe pulmonary involve-
ment associated with EBV infection is a rare but potentially fatal complication of infectious mononu-
cleosis. Similar cases reported in the literature are reviewed, and the therapeutic options for this
particular complication are discussed.
Infectious mononucleosis is a worldwide, highly prevalent
herpesvirus infection caused by Epstein-Barr virus (EBV). The
disease is the result of a primary infection that occurs mostly
early in life. During childhood, nonspecific symptoms or even
a subclinical course prevail, whereas in adolescents the disease
often leads to considerable morbidity [I]. Typically, the pa-
tients present with the triad of fever, pharyngitis, and lymph-
adenopathy, and splenomegaly is usually found on physical
examination. Secondary immunologic responses are thought to
play an important role in complicated courses, which may af-
fect the heart, brain, and other organs [2, 3]. Severe clinical
courses with complications requiring hospital treatment occur
in merely 5% of the cases; however, only 100 fatal outcomes
have been registered in the United States during a period of
10 years [4-6]. Case fatalities occur mainly in association with
fulminant hepatitis, encephalitis, hemophagocytic syndrome,
and splenic rupture [7-10].
Recently, we took care of a young, otherwise healthy adult
who had life-threatening pneumonitis with severe hypoxemia
in the course of an acute EBV infection. By exclusion of other
causative agents, the pulmonary involvement was considered
to be an EBV-related complication. Just a few similar cases
have been reported in the literature; these are reviewed.
Case Report
In January 1994 a 30-year-old student at a police academy
presented because of a lO-day history of fever, sore throat,
swelling of the cervical lymph nodes, myalgias, and fatigue.
He was seen by a physician, who prescribed a macrolide antibi-
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otic that produced no improvement in the patient's condition.
Cough and progressive dyspnea developed, and he was admit-
ted to another hospital, where bilateral pneumonia with marked
partial respiratory insufficiency (arterial partial pressure ofoxy-
gen [Pao-], 5.32 kPa; arterial partial pressure of CO2, 3.8 kPa;
and arterial blood saturation with oxygen [Sao-], 78%) was
diagnosed. Therapy with amoxicillin/clavulanic acid was be-
gun. Because ofprogressive respiratory failure, the patient was
intubated and mechanically ventilated. Hypoxemia persisted
(Pao-, 7.0 kPa, despite an FI02 of 1.0), and the patient was
transferred to our hospital.
On admission, the patient was noted to have well-developed
muscles. He was orally intubated. The pulse rate was 100;
blood pressure, 140/80 mm Hg; and temperature, 37°C. He
appeared slightly cyanotic. No rash or lymphadenopathy was
found. The pharynx was red and the tonsils were normal. End-
inspiratory crackles were heard over both lungs. The liver was
firm and enlarged, reaching 10 em below the right costal mar-
gin. The spleen was palpable 3 cm below the left costal margin.
The remaining examination findings were unremarkable.
The chest roentgenogram obtained on the day of admission
showed bilateral diffuse, confluent infiltrates, particularly in the
middle and lower fields (figure IA). The electrocardiographic
findings were normal. The hemoglobin level was 11 g/dL, and
the leukocyte count was 8.4 X 1031pL, with 40% lymphocytes
(more than one-half of which were atypical [23% of leuko-
cytes]). The following other values were noted: C-reactive
protein, 156 mg/dL (normal, <10 mg/dL); total protein, 41
giL (65-79 gIL); bilirubin, 32 pmol/L «22 pmol/L); serum
aspartate aminotransferase, 193 U/L «60 U/L); serum alanine
aminotransferase, 193 U/L «60 U/L); creatine kinase, 316
U/L «50 U/L); and lactic dehydrogenase, 911 U/L (230-460
U/L). The lactate, creatinine, and coagulation parameters were
normal. Ultrasonography of the abdomen confirmed hepato-
splenomegaly but disclosed no other pathological findings. Ex-
amination of the scarce tracheal aspirate revealed very few
cells and no bacteria on a gram stain.
A pulmonary catheter was inserted, revealing high cardiac
output and a normal pulmonary capillary wedge pressure. Intra-
CID 1995;21 (July) Epstein-Barr Virus Pneumonia 207
Figure 1. A, Chest roentgenogram obtained on admission, showing
intense, diffuse bilateral infiltrates without pleural effusion. B, Chest
roentgenogram obtained 2 days before discharge, showing significant
resolution of the pulmonary infiltrates.
venous therapy with amoxicillinlclavulanic acid was continued,
and erythromycin was added to the regimen. In addition, a
corticosteroid regimen was begun (100 mg of prednisone
daily). Arterial blood gas measurements showed continuous
marked hypoxemia (Pao-, 6.5 kPa; Sao-, 68%) despite an F102
of 1.0 and a positive end-expiratory pressure of 10 mbar. An
intravascular oxygenator was implanted through a section in
the right femoral vein. Over the next 10 hours, central venous
and arterial oxygenation improved markedly; 36 hours later,
the respiratory situation had significantly improved, and the
intravascular oxygenator was removed. Four days after admis-
sion, a macular-papular exanthema was observed on the trunk.
Four days later, amoxicillinlclavulanic acid and erythromycin
were withdrawn and therapy with vancomycin and ceftazidime
was begun because of a catheter-related infection due to coagu-
lase-negative staphylococci. After a total of 11days ofmechan-
ical ventilation, the patient was extubated and the steroid doses
were tapered.
All blood cultures and cultures oftracheal aspirates remained
negative. Serological tests disclosed the following findings:
heterophil antibodies (monospot test), positive; EBV viral cap-
sid antigen IgM, positive; EBV viral capsid antigen IgG titer,
1:1,280; EBV nuclear antigen, negative; EBV early antigen (D
and R) IgG titer, 1:160; cytomegalovirus (CMV) IgG, negative;
and CMV IgM, questionably positive. Both the EBV and CMV
serologies were performed by two independent laboratories
and yielded the same results. Serological tests for Mycoplasma
pneumoniae, Legionella pneumophila, Q-fever, Brucella spe-
cies, Chlamydia species, influenza A and B viruses, parainflu-
enza 1 and 2 viruses, adenovirus, picornavirus (echovirus, cox-
sackievirus), and measles virus (all by complement fixation)
and for HIV and respiratory syncytial virus (by ELISA) were
negative, including control tests performed 2 weeks later. Six-
teen days after admission the patient was discharged from the
hospital. He was in good condition and has resumed his training
at the police academy. A chest roentgenogram obtained at the
time of discharge is shown in figure 1B.
Discussion
This patient presented many classical features of infectious
mononucleosis, including the signs at initial presentation (fe-
ver, pharyngitis, cervical lymphadenopathy, abnormallympho-
cyte counts, and elevated liver enzyme levels), the rash that
developed during aminopenicillin therapy, and a positive EBV
serology. The severe pulmonary involvement in the course of
his acute EBV infection, however, is an unusual complication
that is rarely reported. The negative bacterial cultures and sero-
logical tests made a diagnosis of coinfection with a second
agent unlikely. Furthermore, noninfectious causes (including
acute respiratory distress syndrome and cardiac pulmonary
edema) were excluded on the bases of normal lung compliance
during mechanical ventilation, absence of productive protein-
rich lung secretions, and normal cardiac performance values.
There was no evidence that this patient had an underlying
immunological defect predisposing to a severe course of pri-
mary EBV infection.
In systematic radiographic studies of infectious mononucleo-
sis, pulmonary involvement is detectable in 5%-10% of the
cases [11]. However, these findings appear to be clinically
insignificant, since discrete pulmonary symptoms may be ne-
glected because of other, predominant EBV -related symptoms.
We have found in the literature descriptions of 12 immunocom-
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Table 1. Characteristics of previously reported cases of EBV infection with symptomatic lung involvement.
Patient's
Case no. [reference] age (y)/sex Hypoxemia Chest roentgenographic findings Outcome
1 [12] 48IM + Bilateral diffuse infiltrates, mediastinal lymphadenopathy Recovery
2 [13] 211M NS Peribronchial infiltrates Recovery
3 [14] 171M + Diffuse interstitial infiltrates, right-sided pleural effusions Death, ARDS*
4 [14] 221M + Diffuse patchy infiltrates Recovery
5 [15] 31/F NS Interstitial lung edema, left-sided pleural effusion Recovery
6 [16] <11M NS Bilateral infiltrates Recovery
7 [16] 17/F NS Diffuse bilateral patchy infiltrates Recovery
8 [17] 4/F NS Bilateral interstitial infiltrates Recovery
9 [18] 48IM + Bilateral interstitial infiltrates Recovery*
10 [19] 181M NS Right-sided pleural effusion Recovery
11 [20] 221M NS Bilateral infiltrates, pleural effusion Recovery
12 [21] 16/F + Diffuse pulmonary infiltrates Recovery
NOTE. ARDS = acute respiratory distress syndrome; NS = not specified; + = positive.
* Patients 3 and 9 were supported by mechanical ventilation.
petent patients with acute EBV infection who had symptomatic
lung involvement (table 1). Significant hypoxemia was docu-
mented in 5 patients; 2 required mechanical ventilation and 1
died of pulmonary failure. The radiologic examinations re-
vealed diffuse interstitial infiltrates, which occur unilaterally
or bilaterally and may show concomitant pleural effusions. In
one case, lung tissue was examined histologically [12]. Mono-
nuclear infiltrations were found predominantly in the perivascu-
lar and peribronchial tissues and were also detected in the
intraalveolar septa. These findings, however, did not differ from
the findings in other cases of viral pneumonia.
Clinically, severe hypoxemia appears to be a predominant
feature of EBV-related pneumonitis. In our case, mechanical
ventilation did not increase blood oxygen saturation suffi-
ciently, a circumstance that encouraged us to advocate oxygen-
ation by means of implantation of an intravascular gas ex-
changer. The beneficial role of such devices has not been estab-
lished, although it appears that they have contributed
significantly to survival in individual cases [22, 23]. Although
blood oxygenation improved markedly following implantation
of the intravascular oxygenator in our patient, it cannot be
excluded that the rapid improvement occurred spontaneously
or was the result of corticosteroid therapy.
The role of corticosteroids in treatment of acute EBV infec-
tions is still controversial. Controlled studies of uncomplicated
cases of mononucleosis showed no clinical benefit [24]; how-
ever, for cases involving complications that are believed to be
secondary immunopathological reactions (such as hemolytic
anemia, encephalitis, and myocarditis), the administration of
steroids has been recommended. It remains unclear whether
pulmonary involvement in EBV infections is the result ofdirect
viral invasion of lung tissue or whether it represents an immu-
nological reaction. Our experience with the case presented
herein would encourage us to use steroids again in the treatment
of severe EBV-related pneumonitis.
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